SOLVSolventum

$87.38+17% 1Y

Is the business good?

Mixed

The checks split: nothing decisive, though thin cash backing (0.1×).

1 to watch, 3 neutral
Fundamental health (F-score)6 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash0.12×derived · Jun 30, 2026

Operating profit outpaces operating cash flow, watch accruals and working capital. Conversion is worsening vs a year ago.

Margin direction, 3 yearsStable

Margins have held roughly steady, a stable cost structure.

Where ROE comes from11% ROA

Margin-driven, fat margins on slower asset turns. ROE 30% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbottom 9% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is SOLV?

Solventum earns 17% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

17%

Return on invested capital · cost of capital 9.0% · 8.3 points above what the capital costs: growth creates value

Operating margin
25%

Operating margin · Medical Instruments & Supplies median 6.6% · 12 months to Q2 2026

Cash conversion
0.12×

Cash conversion · 0.95× a year ago · the operating profit has not turned into cash yet

Share count, year on year
−1.1%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY202221%
FY202321%
FY202413%
FY202526%
Details›
Gross margin12 months to Q2 2026
55%
Operating margin12 months to Q2 2026
25%
Net margin12 months to Q2 2026
17%
Free cash flow margin
−1.4%
R&D as % of revenue
8.7%
Revenue, trailing twelve months
$8.31B
Free cash flow, trailing twelve months
−$118M
Net income, trailing twelve months
$1.43B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
17%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.